Viimased lisandused - Retinal Vascular Disease
|
Cotton Wool Spots following cardio-pulmonary bypassvaatamisi: 88The patient had emergency thoracotomy about 3 weeks ago he had an aortic dissection with a root aneurysm. It had dissected down to the iliacs. The patient had a thoracotomy and aortic valve replacement and large aortic graft.märts 15, 2026
|
|
Cotton Wool Spots following cardio-pulmonary bypassvaatamisi: 114The patient had emergency thoracotomy about 3 weeks ago he had an aortic dissection with a root aneurysm. It had dissected down to the iliacs. The patient had a thoracotomy and aortic valve replacement and large aortic graft.märts 15, 2026
|
|
Cotton Wool Spots following cardio-pulmonary bypassvaatamisi: 115The patient had emergency thoracotomy about 3 weeks ago he had an aortic dissection with a root aneurysm. It had dissected down to the iliacs. The patient had a thoracotomy and aortic valve replacement and large aortic graft.märts 15, 2026
|
|
Cotton Wool Spots following cardio-pulmonary bypassvaatamisi: 124The patient had emergency thoracotomy about 3 weeks ago he had an aortic dissection with a root aneurysm. It had dissected down to the iliacs. The patient had a thoracotomy and aortic valve replacement and large aortic graft.märts 15, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 27160 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 29760 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 28460 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 19760 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 16460 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 18560 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 19960 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 16460 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 16160 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 20260 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 18560 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 16060 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 12760 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 16860 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 18260 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 15560 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 16860 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 14860 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 16060 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 18760 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 17160 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 17460 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 16060 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvaatamisi: 15760 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUjaan 11, 2026
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 13081 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 15481 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 13781 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 13581 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 12781 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 13781 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 14381 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 14481 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 17381 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 14781 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 14081 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 13981 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 13581 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 17781 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 16781 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 17381 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 17281 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 12981 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 12681 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 16781 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 13081 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 14781 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 12081 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvaatamisi: 14459 year old man - asymptomatic - not diabeticdets 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvaatamisi: 12459 year old man - asymptomatic - not diabeticdets 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvaatamisi: 11659 year old man - asymptomatic - not diabeticdets 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvaatamisi: 10259 year old man - asymptomatic - not diabeticdets 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvaatamisi: 11459 year old man - asymptomatic - not diabeticdets 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvaatamisi: 18359 year old man - asymptomatic - not diabeticdets 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvaatamisi: 12559 year old man - asymptomatic - not diabeticdets 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvaatamisi: 9959 year old man - asymptomatic - not diabeticdets 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvaatamisi: 15759 year old man - asymptomatic - not diabeticdets 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvaatamisi: 14959 year old man - asymptomatic - not diabeticdets 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvaatamisi: 14459 year old man - asymptomatic - not diabeticdets 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvaatamisi: 14259 year old man - asymptomatic - not diabeticdets 17, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 16664 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 17464 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 18464 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 12764 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 16564 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 13664 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 15164 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 16864 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 13464 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 12164 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 16664 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 14764 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 15064 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 13564 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 17964 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 16364 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 12164 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
Severe NPDR with non-perfusion on FAvaatamisi: 19564 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationnov 23, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 17278 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 14478 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 18478 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 16678 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 14078 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 13278 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 17378 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 14578 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 15078 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 13678 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 16278 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 16178 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 15478 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 13478 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 15357 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 11657 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 15457 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 12557 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 10757 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
|
|
